BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction

CNS Drug Reviews

Volumn 9, Issue 2, 2003, Pages 141-158

  Garcia Ladona, F J ^a   Cox, B F ^b  

^a ABBOTT GMBH AND CO KG   (Germany)

^b ABBOTT LABORATORIES   (United States)

Author keywords

BP 897; Cocaine; Craving; D3 receptors; Drug abuse; Withdrawal

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 6 HYDROXYDOPA; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BP 897; CYCLIC AMP; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; EMONAPRIDE; FORSKOLIN; IODINE 125; LEVODOPA; MORPHINE; PROTEIN C FOS; QUINPIROLE; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SPIPERONE; SULPIRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CATALEPSY; CELL STRAIN; CELL STRAIN COS7; CELL STRAIN NG108 15; CHO CELL; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG STRUCTURE; DYSKINESIA; HYPOTHERMIA; IC 50; MITOGENESIS; MOUSE; NONHUMAN; PARKINSONISM; PROTEIN EXPRESSION; RAT; REINFORCEMENT; REVIEW; RHESUS MONKEY; SUBSTANTIA NIGRA; WITHDRAWAL SYNDROME;

EID: 0041866265     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2003.tb00246.x     Document Type: Review

References (104)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 1996;93:1945-1949.
2. 3 receptor ligands. Eur J Pharmacol 1995;281:R7-R9.
3. 3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 1998;287:187-197.
4. 3 receptor partial agonist blocks the expression of conditioned activity. Neuroreport 2002;13:173-176.
5. Aulakh CS, Wozniak KM, Haas M, Hill JL, Zohar J, Murphy DL. Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. Eur J Pharmacol 1988;146:253-259.
6. 3R agents in drug abuse? Behav Pharmacol Soc Eur Behav Pharmacol Soc 1999;[Abstract].
7. 3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behav Pharmacol 2001;12:1-11.
8. 3 knock-out and wild-type mice. Neuropharmacology 1999;38:555-565.
9. 3 receptor agonists. Neuropharmacology 1999;38:1389-1396.
10. Bowery B, Rothwell LA, Seabrook GR. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area. Br J Pharmacol 1994;112:873-880.
11. 2 receptor antagonist L-741,626. Br J Pharmacol 1996;119:1491-1497.
12. 3 dopamine receptor in cocaine-cue conditioning: An in vivo electrophysiological study. Dopamine 2002;P2.4:126 [Abstract].
13. 3 dopamine receptors. Science 1993;260:1814-1816.
14. 3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuroreport 1997;8:2373-2377.
15. 4.4 receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1999;127:1135-1144.
16. Deutch A, Lee MC, Iadarola M. Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci 1992;3:332-341.
17. Eriksson E, Svensson K, Clark D. The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat. Life Sci 1985;36:1819-1827.
18. Fischman MW, Johanson CE. Cocaine. In: Schuster Ch. R., Kuhar MJ, Eds. Pharmacological aspects of drug dependence. Vol. 118. Heidelberg: Springer-Verlag, 1996:159-195.
19. 3 receptor agonist in developing rats. Eur J Pharmacol 1996;302:1-6.
20. Gawing FH. Neuroleptic reduction of cocaine-induced paranoia but not euphoria. Psychopharmacology (Berl) 1986;90:142-143.
21. Gawing FH. Cocaine addiction: Psychology and neurophysiology. Science 1991;251:1580-1586.
22. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379:606-612.
23. 3 receptor partial agonists: Molecular design and pharmacological investigations. Dopamine 2002;P1.24:74 [Abstract].
24. Graybiel AM, Moratalla R, Robertson HA. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 1990;87:6912-6916.
25. 3 receptor antagonists. Eur Neuropsychopharmacol 1997;7:S120.
26. 1 agonist (ABT-431) on smoked cocaine self-administration in humans, Psychopharmacologia 1999;143:102-110.
27. Herrling S, Woods JH. Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: Reciprocal modification of rate-altering effects of drugs. J Pharmacol Exp Ther 1980;214:354-361.
28. 3 receptor. Soc Neurosci 2000;[Abstract].
29. Hubner CB, Koob GF. Bromocriptine produces decreases in cocaine self-administration in the rat. Neuropharmacology 1990;3:101-108.
30. Jaffe JH. Drug addiction and drug abuse. In: Goodman Gilman A, Rall TW, Nies AS, et al., Eds. The pharmacological basis of therapeutics. New York: McGraw-Hill Inc., 1992:522-573.
31. 3 receptors, from anatomy to neuropsychiatry. NeuroSci News 1999;2:11-21.
32. 3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacol Ther 2001;90:231-259.
33. 3 receptors. J Biol Chem 1999;274:29406-29412.
34. Kelland MD, Freeman AS, Chiodo LA. (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Eur J Pharmacol 1989;169:11-21,
35. 3 receptor mutant mice. J Neurosci 1998;18:2231-2238.
36. Koob GF. Drugs of abuse: Anatomy, pharmacology and function of reward pathways, TIPS 1992;13:177-184.
37. 3 receptor binding affinities. Eur J Pharmacol 1995;277:209-214.
38. Kuhar MJ, Pilotte NS. Neurochemical changes in cocaine withdrawal. TIPS 1996;17:260-264.
39. 3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 1993;18:187-192.
40. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography, Eur J Neurosci 1993;5:145-153.
41. Laurier LG, Corrigall WA, George SR. Dopamine receptor density, sensitivity and mRNA levels are altered following self-administration of cocaine in the rat. Brain Res 1994;634:31-40.
42. 3 receptor modulates reactivity to cocaine, morphine, and nicotine-associated cues: Role of the somatosensory cortex. Dopamine 2002;P2.10:132 [Abstract].
43. 3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 2000;15:140-146.
44. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur J Pharmacol 1995;275:R7-R9.
45. 3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study. J Pharmacol Exp Ther 1993;264:991-1001.
46. 2 dopamine receptors by nafadotride. Neuropsychopharmacology 1997;17:67-71.
47. 3 receptors. Relevance for the drug treatment of Parkinson's disease. CNS Drugs 1999;12:391-402.
48. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 1992;89:8155-8159.
49. 3 receptors to inhibit tuberoinfundibular dopaminergic neurons. Brain Res Bull 2000;52:567-572.
50. MacGibbon GA, Lawlor PA, Bravo R, Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res Mol Brain Res 1994;23:21-32.
51. 35S-binding. J Pharmacol Exp Ther 1998;285:119-126.
52. 3 dopamine receptors linked to the development of cocaine dependence? Mol Psychiatry 1997;2:7-8.
53. Meador-Woodruff JH, Little KY, Damask SP, Mansour A, Watson SJ. Effects of cocaine on dopamine receptor gene expression: A study in the postmortem human brain. Biol Psychiatry 1993;34:348-355.
54. Mello NK, Negus SS. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 1996;14:375-424.
55. 3 receptors. Cerebral Cortex 1991;6:561-570.
56. 2 receptors elicits prolactin secretion and catalepsy. J Pharmacol Exp Ther 1995;275:885-898.
57. 3-receptors. I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626. J Pharmacol Exp Ther 2000;293:1048-1062.
58. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 1994;91:11271-11275.
59. Nader MA, Green KL, Luedtke RR, Mach RH. The effects of benzamide analogues on cocaine self-administration in rhesus monkeys. Psychopharmacologia 1999;147:143-152.
60. 1A receptors as a function of receptor: G-protein stoichiometry. Neuropharmacology 1997;36:451-459.
61. 35S]thio)-triphosphate binding and antibody study. Mol Pharmacol 1999;55:564-574.
62. Ng JP, Hubert GW, Justice JB Jr. Increased stimulated release and uptake of dopamine in nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry. J Neurochem 1991;56:1485-1492.
63. O'Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, Eds. The pharmacological basis of therapeutics. 10th Edition. McGraw-Hill, 2001:621-642.
64. 3 receptors in thermoregulation: A reappraisal. Neuroreport 2000;11:221-225.
65. 3 receptor-preferring agonist: Comparison to other dopamine receptor agonists. Eur J Pharmacol 1996;312:35-44.
66. 3 receptor agonist. Nature 1999;400:371-375.
67. 3 receptors. Soc Neurosci 2001;27:647.16
68. Pouletty P. Drug addictions: Towards socially accepted and medically treatable diseases. Nat Rev Drug Discovery 2002;1:731-736.
69. Pulvirenti L, Koob GF. Lisuride reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 1994;47:819-822.
70. Pulvirenti L, Koob GF. Dopamine receptor agonists, partial agonists and psychostimulant addiction. TIPS 1994;15:374-379.
71. 3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci Biobehav Rev 2001;25:427-443.
72. 3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: Opposite and synergistic functional interactions. Eur J Neurosci 1998;10:1676-1686.
73. Roberts DCS, Vickers G. Atypical neuroleptics increase self-administration of cocaine: An evaluation of a behavioural screen for antipsychotic activity. Psychopharmacology (Berl) 1984;82:135-139.
74. Roberts DCS, Loh EA, Vickers G. Self-administraton of cocaine on a progressive ratio schedule in rats: Dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology (Berl) 1989;97:535-538.
75. Robertson GS, Fibiger HC. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine. Neuroscience 1992;46:315-328.
76. Rocha B. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1998;1:132-137.
77. 2 dopamine receptor activation. Synapse 1994;18:233-240.
78. 123I][beta]-CIT as SPECT tracers for the dopamine transporter: A comparative analysis in nonhuman primates. Nucl Med Biol 2000;27:13-21.
79. 3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 2001;276:30308-30314.
80. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopamine denervation and in Parkinson's disease. Naunyn-Schmiedeberg's Arch Pharmacol 1985;329:227-235.
81. SCRIP. Bioproject acquires GlaxoSmithKline research unit. SCRIP World Pharm News 2001;2679:11.
82. 3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells. Br J Pharmacol 1994;111:391-393.
83. 3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 1997;45:335-339.
84. 2-like dopamine receptor agonists. Science 1996;271:1586-1589.
85. 3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys. Drug Alcohol Depend 1999;54:97-110.
86. 3 as a target for neuroleptics. Nature 1990;347:146-151.
87. 3 dopamine receptor. Arzneimittelforschung 1992;42:224-230.
88. 3 as a novel target for antipsychotics. Biochem Pharmacol 1992;43:659-666.
89. 2 dopamine receptors in the behavioral effects of cocaine. Neurochem Int 1992;20(Suppl):147S-152S.
90. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996;16:6100-6106.
91. Steiner H, Gerfen CR. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 1993;13:5066-5081.
92. 3 receptor agonist/antagonist in primate model of Parkinson's disease. Soc Neurosci Abstr 1999;25:640.
93. Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol Exp Ther 1994;270:1387-1396.
94. 3 receptors in Chinese hamster ovary cells. J Pharmacol Exp Ther 1999;290:908-916.
95. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002;22:9595-9603.
96. 3 receptors. Synapse 1996;23:152-163.
97. 1 agonist SKF 81297 in rhesus monkeys. Psychopharmacology (Berl) 1993;113:51-52.
98. Weiss F, Markou A, Lorang MT, Koob GF. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 1992;593:314-318.
99. Werkman TR, Kruse CG, Nievelstein H, Long SK, Wadman WJ. In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs. Neuropharmacology 2001;40:927-936.
100. 3 receptors. Eur J Pharmacol 2001;424:85-90.
101. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol 2000;6:243-251.
102. Withers NW, Pulvirenti L, Koob GF, Gillin JC. Cocaine abuse and dependence. J Clin Psychopharmacol 1995;15:63-78.
103. 3 receptor. Eur J Pharmacol 2000;407:47-51.
104. 3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology 2001;41:351-359.